Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid
- 29 October 1985
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 132 (1) , 245-252
- https://doi.org/10.1016/0006-291x(85)91014-9
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic StudiesHepatology, 1984
- Hepatotoxicity to sodium valproate: a review.Gut, 1984
- Valproic Acid and Metabolites: Pharmacological and Toxicological StudiesEpilepsia, 1984
- Influence of valproic acid on hepatic carbohydrate and lipid metabolismArchives of Biochemistry and Biophysics, 1983
- Sodium Valproate in the Induction of Unusual HepatotoxicityHepatology, 1982
- Valproate–Induced Hepatic Injury: Analyses of 23 Fatal CasesHepatology, 1982
- INHIBITION OF FATTY ACID OXIDATION BY VALPROATEThe Lancet, 1980
- The occurrence of C6–C10-dicarboxylic acids in urine from patients and rats treated with dipropylacetateBiochemical Medicine, 1980
- Valproic AcidNew England Journal of Medicine, 1980
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979